Zhejiang Tailin Bio-technology Co., Ltd. announced the review results of its application for issuing convertible bonds. The Shenzhen Stock Exchange Listing Committee decided to postpone the review. The company will closely monitor the progress and fulfill information disclosure obligations. Investors are advised to pay attention to further announcements and investment risks.
Summary generated by AI · Always verify with source document
Securities Code: 300813
Securities Abbreviation: Tailin Bio-technology
Announcement No.: 2026-051
Zhejiang Tailin Bio-technology Co., Ltd.
Announcement on the Review Results of the Application for Issuance of Convertible Corporate Bonds to Unspecified Objects by Zhejiang Tailin Bio-technology Co., Ltd. to the Shenzhen Stock Exchange Listing Committee
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.